MARK1 Antibody Summary
| Immunogen |
Recombinant protein encompassing a sequence within the N-terminus region of human MARK1. The exact sequence is proprietary.
|
| Localization |
Cytoplasm, cytoskeleton
|
| Predicted Species |
Mouse (98%), Rat (98%), Bovine (98%), Zebrafish (94%), Xenopus (96%). Backed by our 100% Guarantee.
|
| Isotype |
IgG
|
| Clonality |
Polyclonal
|
| Host |
Rabbit
|
| Gene |
MARK1
|
| Purity |
Immunogen affinity purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
| Theoretical MW |
89 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
Reactivity Notes
Xenopus laevis (96%).
Packaging, Storage & Formulations
| Storage |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
|
| Buffer |
0.1M Tris (pH 7.0), 0.1M Glycine and 10% Glycerol
|
| Preservative |
0.01% Thimerosal
|
| Concentration |
1 mg/ml
|
| Purity |
Immunogen affinity purified
|
Alternate Names for MARK1 Antibody
- EC 2.7.11
- EC 2.7.11.1
- KIAA1477serine/threonine-protein kinase MARK1
- MAP/microtubule affinity-regulating kinase 1MGC126512
- MARKMGC126513
Background
MARK1, a MARK type protein kinase, has been shown to phosphorylate the microtubule-associated proteins tau, MAP2, and MAP4 on their microtubule-binding domain causing their dissociation from microtubules.